Chimera Investment Corp has a consensus price target of $6.3, established from looking at the 12 latest analyst ratings. The last 3 analyst ratings were released from UBS, Credit Suisse, and RBC Capital on December 6, 2023, May 19, 2023, and May 17, 2023. With an average price target of $5.67 between UBS, Credit Suisse, and RBC Capital, there's an implied 37.88% upside for Chimera Investment Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
12/06/2023 | CIM | Buy Now | Chimera Investment | $4.11 | 33.82% | UBS | Douglas Harter | → $5.5 | Initiates | → Neutral | Get Alert |
05/19/2023 | CIM | Buy Now | Chimera Investment | $4.11 | 33.82% | Credit Suisse | Douglas Harter | $6.5 → $5.5 | Maintains | Neutral | Get Alert |
05/17/2023 | CIM | Buy Now | Chimera Investment | $4.11 | 45.99% | RBC Capital | Kenneth Lee | $7 → $6 | Maintains | Outperform | Get Alert |
05/09/2023 | CIM | Buy Now | Chimera Investment | $4.11 | 33.82% | Keefe, Bruyette & Woods | Bose George | $6.25 → $5.5 | Maintains | Market Perform | Get Alert |
04/24/2023 | CIM | Buy Now | Chimera Investment | $4.11 | 52.07% | Keefe, Bruyette & Woods | Bose George | $7 → $6.25 | Maintains | Market Perform | Get Alert |
03/09/2023 | CIM | Buy Now | Chimera Investment | $4.11 | 58.15% | Credit Suisse | Douglas Harter | → $6.5 | Reiterates | → Neutral | Get Alert |
03/07/2023 | CIM | Buy Now | Chimera Investment | $4.11 | 70.32% | RBC Capital | Kenneth Lee | → $7 | Reiterates | → Outperform | Get Alert |
10/05/2022 | CIM | Buy Now | Chimera Investment | $4.11 | 70.32% | RBC Capital | Kenneth Lee | $11 → $7 | Maintains | Outperform | Get Alert |
07/18/2022 | CIM | Buy Now | Chimera Investment | $4.11 | 118.98% | Barclays | Mark Devries | $11 → $9 | Maintains | Underweight | Get Alert |
05/23/2022 | CIM | Buy Now | Chimera Investment | $4.11 | 167.64% | RBC Capital | Kenneth Lee | $15 → $11 | Maintains | Outperform | Get Alert |
04/27/2022 | CIM | Buy Now | Chimera Investment | $4.11 | 167.64% | Barclays | Mark Devries | $14 → $11 | Maintains | Underweight | Get Alert |
01/10/2022 | CIM | Buy Now | Chimera Investment | $4.11 | 240.63% | Barclays | Mark Devries | $11 → $14 | Maintains | Underweight | Get Alert |
The latest price target for Chimera Investment (NYSE: CIM) was reported by UBS on December 6, 2023. The analyst firm set a price target for $5.50 expecting CIM to rise to within 12 months (a possible 33.82% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Chimera Investment (NYSE: CIM) was provided by UBS, and Chimera Investment initiated their neutral rating.
There is no last upgrade for Chimera Investment.
There is no last downgrade for Chimera Investment.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chimera Investment, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chimera Investment was filed on December 6, 2023 so you should expect the next rating to be made available sometime around December 6, 2024.
While ratings are subjective and will change, the latest Chimera Investment (CIM) rating was a initiated with a price target of $0.00 to $5.50. The current price Chimera Investment (CIM) is trading at is $4.11, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.